Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19. (2021)
Attributed to:
Assessing the impact of host and virus genetic variability on Filovirus cell entry and infectivity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ymthe.2021.04.022
PubMed Identifier: 33895322
Publication URI: http://europepmc.org/abstract/MED/33895322
Type: Journal Article/Review
Volume: 29
Parent Publication: Molecular therapy : the journal of the American Society of Gene Therapy
Issue: 8
ISSN: 1525-0016